Thank you for the reply, a great summary of some of the indicators. I've been in Neuren since 2011 but I've got very little experience with pharmaceuticals. It feels like us investors and management believe 2591 phase 3 success is more or less in the bag but I'm curious what level of risk and acquirer would apply, would we get an offer that the top shareholders would be happy with? You're point about an exit strategy for them is a good one so maybe the price required won't be as lofty as some on here hope, I guess some of the other figures LittleT has thrown around for TO haven't pleased everyone in the past.
My exit strategy was always post Trof approval, but now that we're there I'm still holding on, haven't sold any. A takeover would be great for me as it would hopefully rip the band-aid off at a premium, but I can't help but think it might be a long and drawn out process like ROW has been.
I'm definitely still interested in what LittleT has to say on the matter if he's willing to share.
Thank you for the reply, a great summary of some of the...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.96 |
Change
-2.150(9.30%) |
Mkt cap ! $2.676B | |||
| Open | High | Low | Value | Volume |
| $22.50 | $22.70 | $20.28 | $24.29M | 1.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 259 | $20.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.98 | 1641 | 2 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.07 |
Change
-2.150 ( 9.39 %) |
||||
| Open | High | Low | Volume | ||
| $22.45 | $22.67 | $20.27 | 399615 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| NEU (ASX) Chart |